Is MGFRF or VYM a better dividend investment in 2026?

MGFRF currently yields 500000.00% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: MGFRF offers higher current income.

What is the dividend yield difference between MGFRF and VYM?

MGFRF has a forward dividend yield of 500000.00% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 499997.59 percentage points.

Home › Compare › MGFRF vs VYM

MGFRF vs VYM: Dividend Comparison 2026

MGFRF yields 500000.00% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MGFRF wins by $4.663521010693878e+33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MGFRF

● Live price

500000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.663521010693878e+33M

Annual income

$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00

Full MGFRF calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — MGFRF vs VYM

📍 MGFRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MGFRF	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MGFRF + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MGFRF pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGFRF

Annual income on $10K today (after 15% tax)

$42,500,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, MGFRF beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGFRF + VYM for your $10,000?

MGFRF: 50%VYM: 50%

100% VYM50/50100% MGFRF

Portfolio after 10yr

$2.331760505346939e+33M

Annual income

$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.96%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGFRF buys

VYM buys

Politician	Chamber	Ticker	Type	Amount	Date
Carol Devine Miller	🏢 House	$VYM	▲ Buy	$15,001 - $50,000	2022-11-02

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMGFRFVYM

Forward yield	500000.00% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.663521010693878e+33M	$27.8K ✓
Annual income after 10y	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓	$278.55
Total dividends collected	$4.6634009849658873e+33M ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MGFRF vs VYM ($10,000, DRIP)

Year	MGFRF Portfolio	MGFRF Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$50,010,700	$50,000,000.00	$11,151	$241.44	+$50.00M → MGFRF
2	$233,748,371,262	$233,694,859,813.08	$12,413	$246.79	+$233748.36M → MGFRF
3	$1,021,074,511,412,696	$1,020,824,400,655,446.10	$13,794	$251.79	+$1021074511.40M → MGFRF
4	$4,168,597,328,794,951,700	$4,167,504,779,067,739,000.00	$15,306	$256.47	+$4168597328794.94M → MGFRF
5	$15,905,475,114,600,665,000,000	$15,901,014,715,458,854,000,000.00	$16,960	$260.84	+$15905475114600664.00M → MGFRF
6	$56,718,938,532,531,060,000,000,000	$56,701,919,674,158,435,000,000,000.00	$18,768	$264.92	+$56718938532531060736.00M → MGFRF
7	$189,031,807,435,623,860,000,000,000,000	$188,971,118,171,394,040,000,000,000,000.00	$20,745	$268.71	+$1.8903180743562385e+23M → MGFRF
8	$588,799,810,476,518,260,000,000,000,000,000	$588,597,546,442,562,100,000,000,000,000,000.00	$22,905	$272.24	+$5.8879981047651824e+26M → MGFRF
9	$1,714,064,268,114,722,600,000,000,000,000,000,000	$1,713,434,252,317,512,700,000,000,000,000,000,000.00	$25,265	$275.51	+$1.7140642681147225e+30M → MGFRF
10	$4,663,521,010,693,878,300,000,000,000,000,000,000,000	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00	$27,842	$278.55	+$4.663521010693878e+33M → MGFRF

MGFRF vs VYM: Complete Analysis 2026

MGFRF — Stock

MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

Full MGFRF Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this MGFRF vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGFRF vs SCHD MGFRF vs JEPI MGFRF vs O MGFRF vs KO MGFRF vs MAIN MGFRF vs VIG MGFRF vs DGRO MGFRF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.